Cite
HARVARD Citation
Madan, A. et al. (2017). Immunogenicity and safety of an AS03-adjuvanted H7N1 vaccine in adults 65 years of age and older: A phase II, observer-blind, randomized, controlled trial. Vaccine. 35 (15), pp. 1865-1872. [Online].